臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ou d l"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 41-65 of 103 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-08-31T06:29:34Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; ANN-LII CHENG; Hsu C.
臺大學術典藏	2021-08-31T06:29:32Z	Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy	Lin Y.-Y.; Tan C.-T.; Chen C.-W.; Ou D.-L.; ANN-LII CHENG; Hsu C.
臺大學術典藏	2021-08-31T06:29:25Z	Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma	Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; ANN-LII CHENG; Hsu C.
臺大學術典藏	2021-08-11T03:46:42Z	Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma	Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; ZHONG-ZHE LIN; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-08-11T03:46:38Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y.; Chen B.-B.; Ou D.-L.; ZHONG-ZHE LIN; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏	2021-05-02T03:56:41Z	Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver Cancer	Ou D.-L.; Tseng S.-J.; Kempson I.M.; Hsu C.-L.; PAN-CHYR YANG; Liao Z.-X.
臺大學術典藏	2021-03-15T07:59:42Z	MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine	Lu J.-W.;Lin Y.-M.;Lai Y.-L.;Chen C.-Y.;Chung-Yi Hu;Tien H.-F.;Ou D.-L.;Lin L.-I.; Lu J.-W.; Lin Y.-M.; Lai Y.-L.; Chen C.-Y.; CHUNG-YI HU; Tien H.-F.; Ou D.-L.; Lin L.-I.
臺大學術典藏	2021-03-15T07:59:41Z	Cytarabine-resistant FLT3-ITD leukemia cells are associated with TP53 mutation and multiple pathway alterations—possible therapeutic efficacy of cabozantinib	Ko Y.-C.;Chung-Yi Hu;Liu Z.-H.;Tien H.-F.;Ou D.-L.;Chien H.-F.;Lin L.-I.; Ko Y.-C.; CHUNG-YI HU; Liu Z.-H.; Tien H.-F.; Ou D.-L.; Chien H.-F.; Lin L.-I.
臺大學術典藏	2021-03-15T07:59:41Z	Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD)	Lu J.-W.;Wang A.-N.;Liao H.-A.;Chen C.-Y.;Hou H.-A.;Chung-Yi Hu;Tien H.-F.;Ou D.-L.;Lin L.-I.; Lu J.-W.; Wang A.-N.; Liao H.-A.; Chen C.-Y.; Hou H.-A.; CHUNG-YI HU; Tien H.-F.; Ou D.-L.; Lin L.-I.
臺大學術典藏	2021-03-09T05:18:38Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:35Z	Induction of DNA damage-inducible gene GADD45�] contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells	Ou D.-L.; Ying-Chun Shen; Yu S.-L.; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:32Z	Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma	Ying-Chun Shen; Ou D.-L.; Hsu C.; Lin K.-L.; Chang C.-Y.; Lin C.-Y.; Liu S.-H.; Cheng A.-L.
臺大學術典藏	2021-02-18T08:01:17Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Shen Y.-C.; JA-DER LIANG; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-02-05T06:29:41Z	CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia	Lin T.-C.;Hou H.-A.;Wen-Chien Chou;Ou D.-L.;Yu S.-L.;Tien H.-F.;Lin L.-I.; Lin T.-C.; Hou H.-A.; WEN-CHIEN CHOU; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I.
臺大學術典藏	2021-02-02T02:47:55Z	Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma	Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; PING-NING HSU; Cheng A.-L.; Hsu C.
臺大學術典藏	2021-01-28T01:06:39Z	KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏	2021-01-04T12:12:28Z	Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD)	Wang A.-N.; Lu J.-W.; Lin L.-I.; Ou D.-L.; HWEI-FANG TIEN; Hu C.-Y.; Hou H.-A.; Liao H.-A.; Chen C.-Y.
臺大學術典藏	2020-06-17T03:01:53Z	Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells	Ou D.-L.;Shen Y.-C.;Sung-Liang Yu;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Hsu C.;Cheng A.-L.; Ou D.-L.; Shen Y.-C.; SUNG-LIANG YU; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; Cheng A.-L.
臺大學術典藏	2020-06-17T03:01:52Z	CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia	Lin T.-C. ;Hou H.-A. ;Chou W.-C. ;Ou D.-L. ;Sung-Liang Yu ;Tien H.-F. ;Lin L.-I.; Lin T.-C.; Hou H.-A.; Chou W.-C.; Ou D.-L.; SUNG-LIANG YU; Tien H.-F.; Lin L.-I.
臺大學術典藏	2020-06-16T07:53:41Z	Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy	Ou D.-L.;Chen C.-L.;Lin S.B.;Hsu C.-H.;Liang-In Lin; Ou D.-L.; Chen C.-L.; Lin S.B.; Hsu C.-H.; LIANG-IN LIN
臺大學術典藏	2020-06-16T07:53:37Z	CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia	Lin T.-C.;Hou H.-A.;Chou W.-C.;Ou D.-L.;Yu S.-L.;Tien H.-F.;Liang-In Lin; Lin T.-C.; Hou H.-A.; Chou W.-C.; Ou D.-L.; Yu S.-L.; Tien H.-F.; LIANG-IN LIN
臺大學術典藏	2020-06-16T07:53:23Z	Cytarabine-resistant FLT3-ITD leukemia cells are associated with TP53 mutation and multiple pathway alterations—possible therapeutic efficacy of cabozantinib	Ko Y.-C.;Hu C.-Y.;Liu Z.-H.;Tien H.-F.;Ou D.-L.;Chien H.-F.;Liang-In Lin; Ko Y.-C.; Hu C.-Y.; Liu Z.-H.; Tien H.-F.; Ou D.-L.; Chien H.-F.; LIANG-IN LIN
臺大學術典藏	2020-05-25T06:52:04Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.;Hsu C;Yen-Shen Lu;Wang D.-S;Fan H.-H;Yu S.-L;Liou J.-Y;Liang J.-D;Shen Y.-C;Ou D.-L; Ou D.-L; Shen Y.-C; Liang J.-D; Liou J.-Y; Yu S.-L; Fan H.-H; Wang D.-S; YEN-SHEN LU; Hsu C; Cheng A.-L.
臺大學術典藏	2020-05-25T06:52:00Z	I�eB kinases increase Myc protein stability and enhance progression of breast cancer cells	Yeh P.-Y;Yen-Shen Lu;Ou D.-L;Cheng A.-L.; Yeh P.-Y; YEN-SHEN LU; Ou D.-L; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:13Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y.; Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Chih-Hung Hsu;Wang M.-J.;Cheng A.-L.;Hsu C.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; CHIH-HUNG HSU; Wang M.-J.; Cheng A.-L.; Hsu C.

Showing items 41-65 of 103 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 50716725 ???header.onlineuser??? : 411 ???header.sponsordeclaration???